View Exam | PowerPak

1. Which of the following investigational treatments for patients with major depressive disorder works as an opioid modulator?

A. ALKS 5461 B. Ketamine C. CERC 301 D. Amitifadine

2. SG is a 68-year-old woman with major depressive disorder and anxiety. She has already failed sertraline therapy and has been switched to citalopram. She has been taking citalopram for 4 weeks with her dose gradually increasing to 20 mg/day. According to her caregiver, she has not had any improvements in her symptoms and has also been displaying symptoms of cognitive dysfunction. Which of the following treatment strategies is MOST appropriate for SG?

A. Her current treatment should be continued for another 4 weeks with no changes to her therapy. B. She should continue to increase her citalopram dose to 40 mg/day. C. She should be discontinued on citalopram and initiated on vortioxetine. D. She should be discontinued on citalopram and initiated on bupropion.

3. Which of the following statements regarding vortioxetine is TRUE?

A. The most common adverse effects are cognitive and sexual dysfunction. B. Vortioxetine is believed to relieve depression primarily through increasing serotonin reuptake. C. The recommended starting dose is 30 mg/day. D. In comparative studies assessing antidepressant effects, vortioxetine has demonstrated cognitive improvements.

4. TRUE or FALSE: A medication class other than selective serotonin reuptake inhibitor (SSRI) may be preferentially beneficial for a patient experiencing cognitive symptoms or inattention.

A. True B. False

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following investigational treatments for patients with major depressive disorder works as an opioid modulator?

3. Which of the following statements regarding vortioxetine is TRUE?

4. TRUE or FALSE: A medication class other than selective serotonin reuptake inhibitor (SSRI) may be preferentially beneficial for a patient experiencing cognitive symptoms or inattention.

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following investigational treatments for patients with major depressive disorder works as an opioid modulator?

3. Which of the following statements regarding vortioxetine is TRUE?

4. TRUE or FALSE: A medication class other than selective serotonin reuptake inhibitor (SSRI) may be preferentially beneficial for a patient experiencing cognitive symptoms or inattention.

« Return to Activity

Customers who Purchased
this Activity also Purchased